HUTCHMED (China) Limited (AIM:HCM)
213.00
-1.00 (-0.47%)
At close: Dec 5, 2025
HUTCHMED (China) Employees
HUTCHMED (China) had 1,811 employees as of December 31, 2024. The number of employees decreased by 177 or -8.90% compared to the previous year.
Employees
1,811
Change (1Y)
-177
Growth (1Y)
-8.90%
Revenue / Employee
246.93K GBP
Profits / Employee
191.45K GBP
Market Cap
1.83B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| Oxford Nanopore Technologies | 1,382 |
HUTCHMED (China) News
- 9 days ago - HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting - GlobeNewsWire
- 4 weeks ago - HUTCHMED Breaks Below 200-Day Moving Average - Notable for HCM - Nasdaq
- 4 weeks ago - Hutchmed (HCM) Completes Enrollment for Global Phase III Lung Cancer Study - GuruFocus
- 4 weeks ago - HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - HUTCHMED (China) Limited (HCM) HUTCHMED (China) Limited Presents at Deutsche Bank ADR Virtual Investor Conference 2025 - Slideshow - Seeking Alpha
- 4 weeks ago - HUTCHMED (HCM) Reveals Significant R&D Advancements in Cancer Treatment - GuruFocus
- 4 weeks ago - HUTCHMED Highlights Pipeline and Business Progress at R&D Updates Event - GlobeNewsWire
- 5 weeks ago - HUTCHMED (China) Limited (HCM) Discusses Antibody Targeted Therapy Conjugates Platform and Lead Candidate HMPL-A251 in R&D Update Transcript - Seeking Alpha